Listed

Arbutus Biopharma Corp: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 14, 2014 and accepted by EDGAR at Aug 14, 2014, 16:50 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$1.8mus-gaap:Revenues
Revenue6 months2014-01-01 to 2014-06-30$6.2mus-gaap:Revenues
Research and development3 months2014-04-01 to 2014-06-30$9.3mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$17.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-04-01 to 2014-06-30−$9.4mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$15.4mus-gaap:OperatingIncomeLoss
Net income3 months2014-04-01 to 2014-06-30−$6.1mus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$24.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.28us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$1.15us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2014-04-01 to 2014-06-30−$8.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow6 months2014-01-01 to 2014-06-30$1.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2014-04-01 to 2014-06-30$246.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure6 months2014-01-01 to 2014-06-30$581.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-06-30$85.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$118.2mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$132.1mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$16.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$26.9mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30$105.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001171843-14-003980. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.